RecruitingNot ApplicableNCT07256522

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger. A Prospective, Randomized, Controlled Study

Sponsor

Konya Beyhekim Training and Research Hospital

Enrollment

60 participants

Start Date

Dec 15, 2025

Study Type

INTERVENTIONAL

Conditions

Efficacy and Safety Randomised Clinical Trial Trigger Finger Splint Therapy Paraffin Bath Peloidotherapy

Summary

Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization. The first group will use a static finger splint that blocks the proximal interphalangeal joint for 6 weeks, along with a home exercise program. The second group will receive paraffin bath therapy, and the third group will receive peloidotherapy, both in combination with home exercises. All patients will receive education about the disease and activity modification. The finger joint-restricting splint and exercises will be applied for 6 weeks. Evaluations will be conducted at baseline, at the end of the 3rd week, and at the end of the 6th week by a blinded assessor. No analgesic or anti-inflammatory medication will be permitted during the study, and patients will be instructed to avoid using analgesics within 24 hours prior to each assessment.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria2

Being between 18 and 75 years of age and willing to participate in the study
Having a diagnosis of idiopathic single trigger finger, Grade 2-3

Exclusion Criteria14

Patients with triggering in more than one finger
Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger
Patients with thumb (pollex) trigger finger
Patients who have undergone any injection or interventional procedure (release surgery) for trigger finger within the past 6 months
Patients who have received physical therapy for the hand within the past 6 months
Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)
Patients with inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, systemic lupus erythematosus, gout, or psoriatic arthritis
Patients with other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, symptomatic hand osteoarthritis, or Dupuytren's contracture) or neurological diseases (e.g., stroke-related hemiparesis, spinal cord injury, brachial plexus injury, multiple sclerosis, or Parkinsonism) affecting the same hand
Patients with musculoskeletal disorders causing pain and/or limitation in the proximal upper extremity on the affected side (e.g., periarthritis, lateral epicondylitis, mononeuropathy, or radiculopathy)
Patients with significant metabolic diseases (e.g., hypothyroidism, Cushing's syndrome, or uncontrolled diabetes)
Patients with any condition that may interfere with treatment, such as open wounds, rashes, local infections, or active malignant disease of the hand
Patients with a history of hand trauma (chronic or repetitive)
Patients unwilling to complete the self-assessment questionnaires either independently or with assistance
Pregnant women